Mkts

Enanta Pharmaceuticals, Inc.

NASDAQ: ENTA
$7.98-0.25 (-3.04%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
7.868.40
52-week range
8.6117.15
Today
Open8.24
Previous close7.98
Volume—
Valuation
Market cap239.70M
P/E ratio—
EPS (TTM)-2.41
Income & risk
Dividend / yield—
Beta0.84
Avg volume241.4K
Discussion

ENTA News

Stories mentioning ENTA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue17,15918,61515,12518,31414,92616,95914,60717,971
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development19,44320,85923,80927,21028,06527,65630,77828,742
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(11,852)(11,253)(18,386)(18,893)(24,527)(23,543)(29,854)(24,185)
Interest Income
Interest Expense2,355
Other Expense
Pretax Income(13,084)(11,914)(18,668)(18,226)(23,949)(22,706)(29,186)(23,053)
Tax Provision7.0024.0032.0029.00(1,305)(416.00)(363.00)(395.00)
Net Income (Loss)(13,091)(11,938)(18,700)(18,255)(22,644)(22,290)(28,823)(22,658)
Earnings Per Share (Basic)(0.45)(0.42)(890.48)(0.85)(1.06)(1.05)(1,373)(1.07)
Earnings Per Share (Diluted)(0.45)(0.42)(890.48)(0.85)(1.06)(1.05)(1,373)(1.07)
Weighted Average Shares Outstanding (Basic)29,04028,74821.0021,37721,35521,23821.0021,180
Weighted Average Shares Outstanding (Diluted)29,04028,74821.0021,37721,35521,23821.0021,180

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ENTA

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ENTA. It last traded at $7.98 (Nov 19, 2026, 4:00 PM ET), down 3.0% on the day. That gives Enanta Pharmaceuticals a market capitalisation of $239.7M.

Over the past 52 weeks ENTA has traded between $8.61 and $17.15.

Revenue for the quarter ended Mar 31, 2026 was $17.2M; a net loss of $13.1M. Revenue was up 15.0% from $14.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$17.2M-$13.1M-76.3%
Dec 31, 2025$18.6M-$11.9M-64.1%
Sep 30, 2025$15.1M-$18.7M-123.6%
Jun 30, 2025$18.3M-$18.3M-99.7%

From Enanta Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…